These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 10668104)
21. Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Martin GR Cephalalgia; 1997 Oct; 17 Suppl 18():4-14. PubMed ID: 9399012 [TBL] [Abstract][Full Text] [Related]
22. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain. Kayser V; Aubel B; Hamon M; Bourgoin S Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238 [TBL] [Abstract][Full Text] [Related]
23. Effects of chronic prenatal ethanol exposure on cGMP content and glutamate release in the hippocampus of the neonatal guinea pig. Butters NS; Reynolds JN; Brien JF Neurotoxicol Teratol; 2003; 25(1):59-68. PubMed ID: 12633737 [TBL] [Abstract][Full Text] [Related]
24. NMDA receptor mediated nitric oxide dependent cGMP synthesis in brain cortex and hippocampus. Effect of ischemia on NO related biochemical processes during reperfusion. Chalimoniuk M; Głód B; Strosznajder J Neurol Neurochir Pol; 1996; 30 Suppl 2():65-84. PubMed ID: 9100245 [TBL] [Abstract][Full Text] [Related]
25. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion. Pu S; Xu B; Kalra SP; Kalra PS Endocrinology; 1996 May; 137(5):1949-55. PubMed ID: 8612535 [TBL] [Abstract][Full Text] [Related]
26. Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine. MacLennan SJ; Cambridge D; Whiting MV; Marston C; Martin GR Eur J Pharmacol; 1998 Nov; 361(2-3):191-7. PubMed ID: 9865508 [TBL] [Abstract][Full Text] [Related]
27. Sumatriptan elicits both constriction and dilation in human and bovine brain intracortical arterioles. Elhusseiny A; Hamel E Br J Pharmacol; 2001 Jan; 132(1):55-62. PubMed ID: 11156561 [TBL] [Abstract][Full Text] [Related]
28. Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Jeong HJ; Chenu D; Johnson EE; Connor M; Vaughan CW Mol Pain; 2008 Nov; 4():54. PubMed ID: 19014464 [TBL] [Abstract][Full Text] [Related]
29. Inhalational anesthetic effects on rat cerebellar nitric oxide and cyclic guanosine monophosphate production. Rengasamy A; Pajewski TN; Johns RA Anesthesiology; 1997 Mar; 86(3):689-98. PubMed ID: 9066336 [TBL] [Abstract][Full Text] [Related]
30. Differential modulation of the glutamate-nitric oxide-cyclic GMP pathway by distinct neurosteroids in cerebellum in vivo. Cauli O; González-Usano A; Agustí A; Felipo V Neuroscience; 2011 Sep; 190():27-36. PubMed ID: 21703332 [TBL] [Abstract][Full Text] [Related]
31. Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder. Boshuisen ML; den Boer JA Psychopharmacology (Berl); 2000 Sep; 152(1):74-9. PubMed ID: 11041318 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological evidence of involvement of nitric oxide pathway in anti-pruritic effects of sumatriptan in chloroquine-induced scratching in mice. Haddadi NS; Ostadhadi S; Shakiba S; Afshari K; Rahimi N; Foroutan A; Dehpour AR Fundam Clin Pharmacol; 2018 Feb; 32(1):69-76. PubMed ID: 28815720 [TBL] [Abstract][Full Text] [Related]
33. Zolmitriptan stimulates a Ca(2+)-dependent K(+) current in C6 glioma cells stably expressing recombinant human 5-HT(1B) receptors. Le Grand B; Panissié A; Perez M; Pauwels PJ; John GW Eur J Pharmacol; 2000 Jun; 397(2-3):297-302. PubMed ID: 10844127 [TBL] [Abstract][Full Text] [Related]
34. NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expression. Belsham DD; Wetsel WC; Mellon PL EMBO J; 1996 Feb; 15(3):538-47. PubMed ID: 8599937 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the human basilar artery contractile response to 5-HT and triptans. Silva SA; Marques FB; Fontes Ribeiro CA Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295 [TBL] [Abstract][Full Text] [Related]
36. NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist. Dijk SN; Francis PT; Stratmann GC; Bowen DM Br J Pharmacol; 1995 Aug; 115(7):1169-74. PubMed ID: 7582540 [TBL] [Abstract][Full Text] [Related]
37. 5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies. Piñeyro G; de Montigny C; Blier P Neuropsychopharmacology; 1995 Nov; 13(3):249-60. PubMed ID: 8602897 [TBL] [Abstract][Full Text] [Related]
38. Nitric oxide responsible for NMDA receptor-evoked inhibition of arachidonic acid incorporation into lipids of brain membrane. Samochocki M; Chalimoniuk M; Strosznajder J Mol Chem Neuropathol; 1996 Sep; 29(1):79-92. PubMed ID: 8887942 [TBL] [Abstract][Full Text] [Related]
39. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Ellwood AJ; Curtis MJ Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503 [TBL] [Abstract][Full Text] [Related]
40. Extracellular Protein Kinase A Modulates Intracellular Calcium/Calmodulin-Dependent Protein Kinase II, Nitric Oxide Synthase, and the Glutamate-Nitric Oxide-cGMP Pathway in Cerebellum. Differential Effects in Hyperammonemia. Cabrera-Pastor A; Llansola M; Felipo V ACS Chem Neurosci; 2016 Dec; 7(12):1753-1759. PubMed ID: 27673574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]